Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Akari Therapeutics Fail-to-Deliver
Total FTD Shares
558
Below Average
FTD / Avg. Volume
2.13%
Low Impact
1-Year Change
-2.3%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Akari Therapeutics has
558
shares failed to deliver, representing 2.13%
of the average daily volume of
26,140
shares. Over the past year, the monthly average FTD is
3,148
shares, with the current level 82% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 1.1 | 558 | -40.13% |
| Jun 30, 2025 | 1.17 | 932 | -54.87% |
| May 30, 2025 | 1.35 | 2.06K | +157.48% |
| Apr 30, 2025 | 1.44 | 802 | -11.48% |
| Mar 28, 2025 | 1.27 | 906 | +131.12% |
| Feb 28, 2025 | 0.87 | 392 | +512.50% |
| Jan 31, 2025 | 1.09 | 64 | -99.19% |
| Dec 31, 2024 | 1.22 | 7.87K | +116.69% |
| Nov 29, 2024 | 1.21 | 3.63K | +1543.44% |
| Oct 31, 2024 | 2.4 | 221 | +0.45% |
| Sep 30, 2024 | 2.95 | 220 | -60.14% |
| Aug 30, 2024 | 3.83 | 552 | +200.00% |
| Jul 31, 2024 | 3.87 | 184 | +820.00% |
| Jun 28, 2024 | 2.7 | 20 | -99.29% |
| May 29, 2024 | 1.79 | 2.81K | +822.62% |
| Apr 29, 2024 | 1.28 | 305 | +916.67% |
| Mar 27, 2024 | 1.86 | 30 | +2900.00% |
| Feb 16, 2024 | 2.24 | 1 | -50.00% |
| Jan 31, 2024 | 2.62 | 2 | -99.86% |
| Dec 20, 2023 | 2.94 | 1.45K | +9593.33% |
| Nov 28, 2023 | 2.9 | 15 | +650.00% |
| Oct 31, 2023 | 3.41 | 2 | n/a |
| Sep 29, 2023 | 3.95 | 2 | -99.94% |
| Aug 08, 2023 | 5 | 3.13K | -91.95% |
| Jul 25, 2023 | 3.76 | 38.83K | +1741.89% |
| Jun 28, 2023 | 3.24 | 2.11K | +975.51% |
| May 22, 2023 | 4.06 | 196 | -87.86% |
| Apr 27, 2023 | 3.6 | 1.61K | -89.05% |
| Mar 27, 2023 | 4.7 | 14.75K | -41.03% |
| Feb 28, 2023 | 6.9 | 25.01K | +625175.00% |
| Jan 12, 2023 | 10.8 | 4 | n/a |